ASO Visual Abstract: Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy

Affiliations

• ¹ Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ² Erasmus University Medical Center, Rotterdam, The Netherlands.
• ³ Department of Radiation Oncology and Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Department of Health Services Research and Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁵ UCLA Medical Center, Los Angeles, CA, USA.
• ⁶ Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. khunt@mdanderson.org.